In prostate cancer cells exposed to SFN treatment, a marked decrease in the levels of inhibitor of apoptosis (IAP) family proteins (cIAP-1, cIAP-2 and XIAP) was detected, which was accompanied by inhibition of NF-κB activation 35. Here, NFKB1 is linked to prostate cancer.